Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
[1-(3-Tert-butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-cyclopropyl-amine → N-[1-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-N-cyclopropyl-3-fluoro-4-oxazol-5-yl-benzamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | [1-(3-Tert-butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-cyclopropyl-amine | HCID 68289566 | — |
| 반응물 | 3-Fluoro-4-oxazol-5-yl-benzoic acid | HCID 68290144 | — |
| 생성물 | N-[1-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-N-cyclopropyl-3-fluoro-4-oxazol-5-yl-benzamide | HCID 68351901 | — |
반응 단계
The title compound is prepared from [1-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-cyclopropyl-amine and 3-fluoro-4-oxazol-5-yl-benzoic acid following a procedure analogous to that described in Example 17. LC (method 1): tR=1.26 min; Mass spectrum (ESI+): m/z=454 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08822471B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-72f6f3b0cba3499c8553271fcf34e465 |
| 출처 메모 | uspto-grants-2014_09 |